HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A role for eukaryotic initiation factor 4B overexpression in the pathogenesis of diffuse large B-cell lymphoma.

Abstract
Dysregulated expression of factors that control protein synthesis is associated with poor prognosis of many cancers, but the underlying mechanisms are not well defined. Analysis of the diffuse large B-cell lymphoma (DLBCL) translatome revealed selective upregulation of mRNAs encoding anti-apoptotic and DNA repair proteins. We show that enhanced synthesis of these proteins in DLBCL is mediated by the relief of repression that is normally imposed by structure in the 5'-untranslated regions of their corresponding mRNAs. This process is driven by signaling through mammalian target of rapamycin, resulting in increased synthesis of eukaryotic initiation factor (eIF) 4B complex (eIF4B), a known activator of the RNA helicase eIF4A. Reducing eIF4B expression alone is sufficient to decrease synthesis of proteins associated with enhanced tumor cell survival, namely DAXX, BCL2 and ERCC5. Importantly, eIF4B-driven expression of these key survival proteins is directly correlated with patient outcome, and eIF4B, DAXX and ERCC5 are identified as novel prognostic markers for poor survival in DLBCL. Our work provides new insights into the mechanisms by which the cancer-promoting translational machinery drives lymphomagenesis.
AuthorsE Horvilleur, T Sbarrato, K Hill, R V Spriggs, M Screen, P J Goodrem, K Sawicka, L C Chaplin, C Touriol, G Packham, K N Potter, S Dirnhofer, A Tzankov, M J S Dyer, M Bushell, M MacFarlane, A E Willis
JournalLeukemia (Leukemia) Vol. 28 Issue 5 Pg. 1092-102 (May 2014) ISSN: 1476-5551 [Electronic] England
PMID24135829 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 5' Untranslated Regions
  • Eukaryotic Initiation Factors
  • RNA, Messenger
  • eIF-4B
Topics
  • 5' Untranslated Regions
  • Cell Line, Tumor
  • Electrophoresis, Polyacrylamide Gel
  • Eukaryotic Initiation Factors (metabolism)
  • Humans
  • Lymphoma, Large B-Cell, Diffuse (metabolism, pathology)
  • Oligonucleotide Array Sequence Analysis
  • RNA, Messenger (genetics)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: